BostonGene CCO Dr. Ferran Prat to Moderate External Innovation Panel at Longwood Healthcare Leaders Boston CEO Conference
WALTHAM, Mass., October 27, 2026--BostonGene, developer of an AI model for tumor and immune biology, today announced that Ferran Prat, PhD, JD, Chief Commercial Officer, will moderate the "Ecosystem of External Innovation" panel at the Longwood Healthcare Leaders Boston CEO conference taking place November 2 - 3, 2026, in Boston. Dr. Prat will join executive leaders to engage in strategic dialogue and explore cross-industry partnerships with biopharma CEOs, heads of research and development, lif BostonGene, developer of an AI model for tumor and immune biology, Ferran Prat, PhD, JD, Chief Commercial Officer at BostonGene, will moderate the "Ecosystem of External Innovation" panel at the Longwood Healthcare Leaders Boston CEO conference in 2026. The session will focus on global sourcing, pipeline resource allocation, regulatory alignment, and responsible AI integration. Prat will also engage in strategic dialogue and explore cross-industry partnerships with biopharma CEOs, heads of research and development, life science investors, and academics. The panel will examine how industry leaders evaluate external scientific assets, navigate cross-border data and regulatory dynamics, and leverage AI to optimize development and deliver meaningful outcomes to patients. BostonGene uses its AI model of tumor and immunity biology to deliver disease-level insights and enable precision decision-making across oncology and immune-mediated diseases.
Publicados : 10 horas atrás por Business Wire no Business Health Tech
Dr. Prat to lead session on global sourcing, pipeline resource allocation, regulatory alignment, and responsible AI integration
WALTHAM, Mass., October 27, 2026--(BUSINESS WIRE)--BostonGene, develope... [2246 symbols]
Tópicos: Business Leaders
